LyGenesis receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also closes $11 Million convertible Debt Financing.
Find more companies like LyGenesis
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.